ADVFN US – Market Content Editor

  • American Fusion Reaches 100 Pending Patent Applications for Texatron Fusion Platform

    American Fusion Reaches 100 Pending Patent Applications for Texatron Fusion Platform

    American Fusion Inc. (USOTC:AMFN) has reached 100 pending patent applications covering its Texatron Fusion Engine platform after filing 17 additional U.S. applications, expanding the intellectual property portfolio surrounding its developing fusion technology. The latest filings focus largely on aluminum-based configurations and alternative structural designs, extending protection across areas including fusion-confinement structures, toroidal chambers, fuel-injection systems,…

  • Xeriant Positions NexBoard as Universal Construction Panel After Independent Testing

    Xeriant Positions NexBoard as Universal Construction Panel After Independent Testing

    Xeriant, Inc. (USOTC:XERI) is positioning its NexBoard composite panel as a universal construction material capable of replacing several traditional building products after independent laboratory testing showed performance advantages across multiple categories. The company says NexBoard could potentially serve applications ranging from interior walls and ceilings to subflooring, roofing underlayment and exterior sheathing, broadening the commercial…

  • Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026

    Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026

    Amarin Corporation plc (NASDAQ:AMRN) will present new REDUCE-IT and EPA analyses at the European Society of Cardiology Congress 2026, adding further research around icosapent ethyl, cardiovascular risk factors and potential mechanisms associated with eicosapentaenoic acid. The presentations, scheduled for August 28 through August 30 during the Munich conference, will examine areas including treatment adherence, longer-term…

  • American EcoFuels Launches Phase 2 Patent Expansion for GTL and CTL Technologies

    American EcoFuels Launches Phase 2 Patent Expansion for GTL and CTL Technologies

    American EcoFuels Inc. (USOTC:AEFI) has launched a Phase 2 patent expansion programme that currently contemplates up to 584 additional applications covering its Gas-to-Liquids and Coal-to-Liquids technology platforms. The intellectual property initiative is designed to broaden protection around the company’s synthetic fuel technologies as American EcoFuels advances toward engineering, testing, certification and potential commercialisation of Sustainable…

  • Kraig Biocraft Laboratories Boosts Spider Silk Production More Than 30% During Rainy Season

    Kraig Biocraft Laboratories Boosts Spider Silk Production More Than 30% During Rainy Season

    Kraig Biocraft Laboratories, Inc. (USOTC:KBLB) has increased spider silk production by more than 30% from its previous record, achieving the higher output during the rainy season despite constraints on the availability of usable mulberry feedstock. The production record provides another operational test for Kraig Labs as it works toward commercial-scale spider silk manufacturing, while management…

  • Eva Live Expands Into International Gaming Through Majority-Owned IGA

    Eva Live Expands Into International Gaming Through Majority-Owned IGA

    Eva Live Inc. (NASDAQ:GOAI) is expanding into international gaming and lottery operations through its 60% ownership of International Gaming Alliance, which has signed a three-year Master Services Agreement with Lottery.com International Limited. The agreement gives Eva Live a majority-owned platform spanning approved activities across Canada, Central America, South America, Southeast Asia and West Africa, while…

  • Capricor Therapeutics Deramiocel PDUFA Date Extended to November as FDA Reviews BLA Amendment

    Capricor Therapeutics Deramiocel PDUFA Date Extended to November as FDA Reviews BLA Amendment

    Capricor Therapeutics (NASDAQ:CAPR) faces a three-month extension to the FDA review timeline for Deramiocel after the agency moved the PDUFA target action date for the Duchenne muscular dystrophy cell therapy from August 22 to November 22, 2026. The extension follows Capricor’s submission of a major amendment containing 24-month open-label extension data from the Phase 3…

  • BTC Digital Georgia 10MW Cryptocurrency Computing Project Nears Deployment Readiness

    BTC Digital Georgia 10MW Cryptocurrency Computing Project Nears Deployment Readiness

    BTC Digital Ltd. (NASDAQ:BTCT) has completed construction of its 10-megawatt cryptocurrency computing infrastructure project in Georgia, with the facility expected to become ready for mining machine deployment and the start of digital asset mining operations within approximately two months. At full deployment, the site is designed to support up to approximately 900,000 TH/s, or 900…

  • Innovative Eyewear Expands Lucyd Armor Into More Than 150 U.S. Retail Stores

    Innovative Eyewear Expands Lucyd Armor Into More Than 150 U.S. Retail Stores

    Innovative Eyewear, Inc. (NASDAQ:LUCY) is expanding Lucyd Armor into more than 150 stores operated by one of the largest big box retailers in the United States, giving the smart eyewear company a potentially significant new physical retail channel. The test rollout is already underway, with sales expected to begin in October. The retailer was not…

  • Roche Elecsys pTau217 Receives FDA Clearance for Alzheimer’s Disease Assessment

    Roche Elecsys pTau217 Receives FDA Clearance for Alzheimer’s Disease Assessment

    Roche (USOTC:RHHBY) has received FDA clearance for its Elecsys pTau217 blood test, giving clinicians in primary and specialty care a new blood-based tool for assessing amyloid pathology associated with Alzheimer’s disease in people aged 55 and older who have signs, symptoms or complaints of cognitive decline. The clearance is commercially significant because Elecsys pTau217 can…